Announcements Trials

Browse Landscape

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 38 Breast Neoplasms 31 Lung Neoplasms 25 Colorectal Neoplasms 15 Prostatic Neoplasms 13 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Head and Neck Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Sarcoma 8 Colonic Neoplasms 8 Uterine Cervical Neoplasms 7 Melanoma 7 Glioma 7 Esophageal Neoplasms 7 Carcinoma, Hepatocellular 7 Lymphoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Neoplastic Cells, Circulating 5 Multiple Myeloma 5 Endometrial Neoplasms 5 Brain Neoplasms 5 Neoplasm, Residual 4 Gastrointestinal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma 4 Thrombosis 3 Skin Neoplasms 3

Interventions

Injections 6 Fluorodeoxyglucose F18 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 fludarabine 2 Specimen Handling 2 Nivolumab 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 trametinib 1 tislelizumab 1 temsirolimus 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 etoposide phosphate 1 enzalutamide 1 envafolimab 1 donafenib 1 disitamab vedotin 1 dabrafenib 1 cemiplimab 1 avelumab 1 atezolizumab 1 anlotinib 1 WW Domain-Containing Oxidoreductase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor × Blood Specimen Collection × Clear all

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡